Return to Trial Database

GI05-92

A Pilot Study With Cetuximab and Radiation Therapy for Patients With Surgically Resectable Esophageal and GE Junction Carcinomas: Hoosier Oncology Group Study (GI05-92)

Status

Study Completed

Cancer Type(s)

Study Contact

Publications

Pre-operative Cetuximab and Radiation (XRT) for Patients (pts) with Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GEJ junction carcinomas

Trial Locations

All sites in which the trial GI05-92 being conducted in.

No data was found